Myriad — Fueling The Debate Over DNA Patents

Law360, New York (September 13, 2011, 12:57 PM EDT) -- The patent-eligibility of biotechnology inventions, in particular, of isolated genes and methods of using isolated genes, has been well settled for decades. Isolated genes, gene fragments and methods of using genes are patent-eligible subject matter. It is estimated that there are over 40,000 issued patents concerning DNA-related inventions. Whether such inventions should, however, be patent-eligible has been continuously debated....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!